Our goal was to measure the effectiveness of IFN-β neutralizing antibody in blocking the autocrine-paracrine induction of IFN-β during Chlamydia infection, and to ascertain which time-point during infection was the most important autocrine-paracrine induction. This evidence concerns the gene IFNB1 and chlamydia infectious disease.